Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Illumina Laboratory Services, |
RCV001249774 | SCV001423808 | likely pathogenic | Camptomelic dysplasia | 2019-11-27 | criteria provided, single submitter | clinical testing | The SOX9 c.503A>G (p.Asp168Gly) variant is a missense variant. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. This variant is not found in the Genome Aggregation Database in a region of good sequence coverage, so the variant is presumed to be rare. The p.Asp168Gly variant is located in the HMG DNA-binding domain of the SOX9 protein, and variants within this domain have been associated with a milder, non-lethal phenotype, including variants at adjacent amino acids His169 and Pro170 (Wada et al. 2009; Corbani et al. 2011; Matsushita et al. 2013). The clinical features of these patients are variable and include dysmorphic facial features (Pierre Robin sequence and/or cleft palate, micrognathia, low-set ears, and anteverted nares), relative macrocephaly, short stature, and skeletal abnormalities (scapular hypoplasia, scoliosis, narrow iliac wings, mild bowing of long bones, limited elbow extension, brachydactyly with clinodactyly of the 5th fingers, humeral and ulnar abnormalities, sandal gap, and defective ischio-pubic ossification). Notably, the p.His169Gln variant was identified in an affected proband and his mildly affected mother (Matsushita et al. 2013). Based on the location of the variant in an important functional domain, its absence from population frequency databases, pathogenic in silico predictions, and cosegregation of the variant in affected family members, the p.Asp168Gly variant is classified as likely pathogenic for campomelic dysplasia. |